| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026842 |
| Receipt No. | R000030806 |
| Official scientific title of the study | Comparison of the medication method of paravertebral block in thoracoscopic lung lobectomy |
| Date of disclosure of the study information | 2017/04/05 |
| Last modified on | 2018/04/18 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Comparison of the medication method of paravertebral block in thoracoscopic lung lobectomy | |
| Title of the study (Brief title) | Comparison of the medication method of paravertebral block in thoracoscopic lung lobectomy | |
| Region |
|
|
| Condition | ||
| Condition | lung cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to investigate the effect of paravertebral block for postoperative analgesia and the different effect depend on the medication method of paravertebral block. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Total amount of fentanyl which was injected by IV-PCA after the surgery |
| Key secondary outcomes | The change of plasma concentration of regional anesthetic agents in both groups. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 0.25% levobupivacaine or 0.2% ropivacaine will be given after the surgery through the catheter of paravertebral block.
16 ml of a local anesthetic will be given every 8 hours until 48 hour after the surgery in a group of intermittently medication method. |
|
| Interventions/Control_2 | 0.25% levobupivacaine or 0.2% ropivacaine will be given after the surgery through the catheter of paravertebral block.
A local anesthetic was given with 6ml/hr until 48 hour after the surgery in a group of continuous medication method. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients of ASA physical status 1 or 2 scheduled for thoracoscopic lung lobectomy | |||
| Key exclusion criteria | 1.Patients of ASA physical status 3 or 4.
2.Patients undergoing artifical dialysis. 3.Patients with hepatic failure. 4.Patients with infection 5.Patients with heart failur (NYHA 3 or 4) 6.patients with a pacemaker because of arrhythmia. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Takahashi Keiya |
| Organization | Asahikawa Medical University |
| Division name | Department of Anesthesiology and Critical Care Medicine |
| Address | 2-1-1-1 Midorigaoka-higashi,Asahikawa,Hokkaido,Japan |
| TEL | 0166652111 |
| k2341@asahikawa-med.ac.jp | |
| Public contact | |
| Name of contact person | Takahashi Keiya |
| Organization | Asahikawa Medical University |
| Division name | Department of Anesthesiology and Critical Care Medicine |
| Address | 2-1-1-1 Midorigaoka-higashi,Asahikawa,Hokkaido,Japan |
| TEL | 0166652111 |
| Homepage URL | |
| k2341@asahikawa-med.ac.jp | |
| Sponsor | |
| Institute | Asahikawa Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Not applicable |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030806 |